159 related articles for article (PubMed ID: 34119324)
1. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.
Juan CC; Chen KH; Chen CW; Ho CH; Wang PH; Chen HS; Hwang JL; Lin YH; Seow KM
Fertil Steril; 2021 Oct; 116(4):1139-1146. PubMed ID: 34119324
[TBL] [Abstract][Full Text] [Related]
2. Expression levels of haem oxygenase-1 in the omental adipose tissue and peripheral blood mononuclear cells of women with polycystic ovary syndrome.
Seow KM; Lin YH; Hwang JL; Wang PH; Ho LT; Lin YH; Juan CC
Hum Reprod; 2011 Feb; 26(2):431-7. PubMed ID: 21148661
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome.
Juan CC; Chen KH; Wang PH; Hwang JL; Seow KM
Fertil Steril; 2015 Jul; 104(1):200-6. PubMed ID: 25935491
[TBL] [Abstract][Full Text] [Related]
4. Expression of visfatin mRNA in peripheral blood mononuclear cells is not correlated with visfatin mRNA in omental adipose tissue in women with polycystic ovary syndrome.
Seow KM; Hwang JL; Wang PH; Ho LT; Juan CC
Hum Reprod; 2011 Oct; 26(10):2869-73. PubMed ID: 21840905
[TBL] [Abstract][Full Text] [Related]
5. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
6. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
7. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism.
Luque-Ramírez M; Alpañés M; Escobar-Morreale HF
Fertil Steril; 2010 Nov; 94(6):2214-21. PubMed ID: 20097337
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
[TBL] [Abstract][Full Text] [Related]
9. Aquaglyceroporin-7 overexpression in women with the polycystic ovary syndrome.
Seow KM; Lin YH; Wang PH; Hwang JL; Ho LT; Juan CC
Gynecol Obstet Invest; 2013; 75(2):126-31. PubMed ID: 23235401
[TBL] [Abstract][Full Text] [Related]
10. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
Hu W; Qiao J; Yang Y; Wang L; Li R
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome.
Cortón M; Botella-Carretero JI; Benguría A; Villuendas G; Zaballos A; San Millán JL; Escobar-Morreale HF; Peral B
J Clin Endocrinol Metab; 2007 Jan; 92(1):328-37. PubMed ID: 17062763
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
13. Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome.
González F; Kirwan JP; Rote NS; Minium J
Am J Obstet Gynecol; 2014 Dec; 211(6):635.e1-7. PubMed ID: 24956549
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.
González F; Sia CL; Shepard MK; Rote NS; Minium J
Hum Reprod; 2012 Dec; 27(12):3560-8. PubMed ID: 22940766
[TBL] [Abstract][Full Text] [Related]
15. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
[TBL] [Abstract][Full Text] [Related]
17. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732
[TBL] [Abstract][Full Text] [Related]
18. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
[TBL] [Abstract][Full Text] [Related]
20. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
